AI tools may help clinicians recognize sepsis earlier, but false alarms, limited external validation, and uncertain effects on patient outcomes complicate their use in adult and neonatal intensive care.
|Articles|December 3, 2013
Researchers Identify Novel Mechanism Wherein HIV-1 May Facilitate its Own Transmission
Advertisement
Infectious disease researchers have identified a novel mechanism wherein HIV-1 may facilitate its own transmission by usurping the antibody response directed against itself. These results have important implications for HIV vaccine development and for understanding the earliest events in HIV transmission.
In a study appearing in the November issue of PLoS Pathogens, Dr. Donald Forthal of UC Irvine and colleagues studied the mechanisms employed by the virus to cross genital tract tissue and establish infection. Since cervicovaginal fluid is acidic and HIV-1 in cervicovaginal fluid is likely coated with antibodies, they explored the effect of low pH and HIV-1-specific antibodies on transcytosis, the movement of HIV-1 across tight-junctioned epithelial cells.
The researchers found that the combination of HIV-1-specific antibodies and low pH enhanced transcytosis as much as 20-fold.
Virus that underwent transcytosis under these conditions was infectious, and infectivity was highly influenced by whether or not the antibody neutralized the virus. They observed enhanced transcytosis using antibody from cervicovaginal and seminal fluids and using transmitted/founder strains of HIV-1. Enhanced transcytosis was due to the Fc neonatal receptor (FcRn), which binds immune complexes at acidic pH and releases them at neutral pH. Finally, staining of human tissue revealed abundant FcRn expression on columnar epithelial cells of penile urethra and endocervix.
The work was supported by the National Institute of Allergy and Infectious Diseases (awards R01AI102715 and U19 AI096398).
Source: UC Irvine
Advertisement
Related to this article
An imported case of Bundibugyo virus disease in Kenya raises questions about airport screening, clinical recognition, and potential exposures, highlighting the importance of coordinated contact tracing and hospital infection prevention readiness.
Florida’s dengue outbreak highlights the importance of recognizing symptoms, identifying warning signs, and preventing mosquito bites. Ubong Johnson, MD, explains local transmission, diagnostic testing, treatment, and practical prevention measures.
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
An unexplained death at a Russian plague research institute has prompted international scrutiny. The incident raises questions about laboratory safety, transparent reporting, and infection prevention preparedness while the cause remains unconfirmed.
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.
This week's coverage in Infection Control Today centered on a common thread: the systems, partnerships, and data that let infection prevention teams catch problems before patients are harmed.
Advertisement
Advertisement